SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?


To: alruss who wrote (542)7/15/1998 12:28:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 1722
 
Johnson & Johnson Raised to Near-Term 'Buy' at Merrill and Zuercher Kantonalbank, Reiterated 'Hold' at BCV

Bloomberg News
July 15, 1998, 5:23 a.m. PT

Princeton, New Jersey, July 15 (Bloomberg Data) -- Johnson & Johnson (JNJ
US) was raised to near-term ''buy'' from near-term ''accumulate'' by analyst
Vivian Wohl at Merrill Lynch & Co. The 12-month target price is $90.00 per
share. The long-term rating remained ''b uy.''

-- Michael Donohue in Princeton, New Jersey, (609)279-3156

Bloomberg News
July 15, 1998, 12:59 a.m. PT

Zurich, July 15 (Bloomberg Data) -- Johnson & Johnson (JNJ US)
was reiterated ''buy'' by analyst Giusep Demont at Zuercher Kantonalbank.
Demont expects an EPS of $2.75 for 1998, and $3.12 for 1999, from $2.47 in
1997.

Johnson & Johnson Reiterated 'Hold' at BCV

Bloomberg News
July 15, 1998, 6:21 a.m. PT

Zurich, July 15 (Bloomberg Data) -- Johnson & Johnson (JNJ US)
was reiterated ''hold'' by analyst Michael Strauss at Banque Cantonale
Vaudoise.

-- Olivier Thommen in Zurich, (41-1) 224 4116



To: alruss who wrote (542)7/15/1998 5:32:00 PM
From: Anthony Wong  Respond to of 1722
 
J&J paltry sales growth seen rebounding
Wednesday July 15, 3:12 pm Eastern Time
biz.yahoo.com



To: alruss who wrote (542)7/15/1998 5:34:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 1722
 
Johnson & Johnson Reiterated 'Strong Buy' at Gruntal

Bloomberg News
July 15, 1998, 11:22 a.m. PT

Princeton, New Jersey, July 15 (Bloomberg Data) -- Johnson & Johnson (JNJ
US) was reiterated ''strong buy'' by analyst David F. Saks at Gruntal & Co.
The 12-month target price is $91.00 per share.

-- Colleen Sferra in Princeton, New Jersey, (609)279-3843